229 related articles for article (PubMed ID: 31368787)
1. The Impact of Placebo Response Rates on Clinical Trial Outcome: A Systematic Review and Meta-Analysis of Antidepressants in Children and Adolescents with Major Depressive Disorder.
Li Y; Huang J; He Y; Yang J; Lv Y; Liu H; Liang L; Li H; Zheng Q; Li L
J Child Adolesc Psychopharmacol; 2019 Nov; 29(9):712-720. PubMed ID: 31368787
[No Abstract] [Full Text] [Related]
2. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
3. Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis.
Meister R; Abbas M; Antel J; Peters T; Pan Y; Bingel U; Nestoriuc Y; Hebebrand J
Eur Child Adolesc Psychiatry; 2020 Mar; 29(3):253-273. PubMed ID: 30535589
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analysis.
Zhou X; Cipriani A; Furukawa TA; Cuijpers P; Zhang Y; Hetrick SE; Pu J; Yuan S; Del Giovane C; Xie P
BMJ Open; 2018 Jan; 8(1):e018357. PubMed ID: 29306886
[TBL] [Abstract][Full Text] [Related]
6. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
7. Factors Related to Placebo Response in Randomized, Double-Blind Clinical Trials of Antidepressants in Children and Adolescents: A Meta-regression Analysis.
Okubo R; Matsui K; Narukawa M
Clin Drug Investig; 2023 Jun; 43(6):383-391. PubMed ID: 37222973
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants in children and adolescents with major depressive disorder and the influence of placebo response: A meta-analysis.
Feeney A; Hock RS; Fava M; Hernández Ortiz JM; Iovieno N; Papakostas GI
J Affect Disord; 2022 May; 305():55-64. PubMed ID: 35247482
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for somatoform disorders in adults.
Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis.
Kato M; Hori H; Inoue T; Iga J; Iwata M; Inagaki T; Shinohara K; Imai H; Murata A; Mishima K; Tajika A
Mol Psychiatry; 2021 Jan; 26(1):118-133. PubMed ID: 32704061
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Evans VC; Alamian G; McLeod J; Woo C; Yatham LN; Lam RW
CNS Drugs; 2016 May; 30(5):405-17. PubMed ID: 27113464
[TBL] [Abstract][Full Text] [Related]
14. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Failed Antidepressant Trials on Outcomes in Children and Adolescents with Anxiety and Depression: A Systematic Review and Meta-Analysis.
Mossman SA; Mills JA; Walkup JT; Strawn JR
J Child Adolesc Psychopharmacol; 2021 May; 31(4):259-267. PubMed ID: 33887154
[No Abstract] [Full Text] [Related]
16. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.
Agabio R; Trogu E; Pani PP
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008581. PubMed ID: 29688573
[TBL] [Abstract][Full Text] [Related]
17. Tricyclic antidepressants versus 'active placebo', placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.
Jørgensen CK; Juul S; Siddiqui F; Barbateskovic M; Munkholm K; Hengartner MP; Kirsch I; Gluud C; Jakobsen JC
Syst Rev; 2021 Aug; 10(1):227. PubMed ID: 34389045
[TBL] [Abstract][Full Text] [Related]
18. Tricyclic antidepressants for depressive disorders in children and adolescents: a meta-analysis of randomized-controlled trials.
Maneeton N; Srisurapanont M
J Med Assoc Thai; 2000 Nov; 83(11):1367-74. PubMed ID: 11215868
[TBL] [Abstract][Full Text] [Related]
19. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder - A systematic review and a meta-analysis.
Tham A; Jonsson U; Andersson G; Söderlund A; Allard P; Bertilsson G
J Affect Disord; 2016 Nov; 205():1-12. PubMed ID: 27389296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
